107 related articles for article (PubMed ID: 9626526)
1. Hyaluronate binding probe and CD44 in the differential diagnosis of malignant effusions: disappointing results in cytology material.
Filie AC; Abati A; Fetsch P; Azumi N
Diagn Cytopathol; 1998 Jun; 18(6):473-4. PubMed ID: 9626526
[No Abstract] [Full Text] [Related]
2. A novel biotinylated probe specific for hyaluronate. Its diagnostic value in diffuse malignant mesothelioma.
Azumi N; Underhill CB; Kagan E; Sheibani K
Am J Surg Pathol; 1992 Feb; 16(2):116-21. PubMed ID: 1733346
[TBL] [Abstract][Full Text] [Related]
3. Significance of immunocytochemical expression of E-cadherin, N-cadherin and CD44 in serous effusions using liquid-based cytology.
Malle D; Valeri RM; Photiou C; Kaplanis K; Andreadis C; Tsavdaridis D; Destouni C
Acta Cytol; 2005; 49(1):11-6. PubMed ID: 15717748
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effects of pleural fluids from mesothelioma patients on CD44 expression, hyaluronan production and cell proliferation in primary cultures of normal mesothelial and transformed cells.
Teder P; Versnel MA; Heldin P
Int J Cancer; 1996 Jul; 67(3):393-8. PubMed ID: 8707414
[TBL] [Abstract][Full Text] [Related]
5. High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma.
Karamanos NK; Hjerpe A
J Chromatogr B Biomed Sci Appl; 1997 Sep; 697(1-2):277-81. PubMed ID: 9342681
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
7. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
Delahaye M; van der Ham F; van der Kwast TH
Diagn Cytopathol; 1997 Aug; 17(2):115-20. PubMed ID: 9258618
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
9. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2000 Apr; 24(4):598-606. PubMed ID: 10757409
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
Asplund T; Heldin P
Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
[TBL] [Abstract][Full Text] [Related]
11. High CD44 expression on human mesotheliomas mediates association with hyaluronan.
Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI
Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronate and CD44 expression patterns in the human placenta throughout pregnancy.
Marzioni D; Crescimanno C; Zaccheo D; Coppari R; Underhill CB; Castellucci M
Eur J Histochem; 2001; 45(2):131-40. PubMed ID: 11512634
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content.
Nurminen M; Dejmek A; Mårtensson G; Thylen A; Hjerpe A
Clin Chem; 1994 May; 40(5):777-80. PubMed ID: 8174251
[TBL] [Abstract][Full Text] [Related]
14. Cytological diagnosis of malignant mesothelioma--improvement by additional analysis of hyaluronic acid in pleural effusions.
Welker L; Müller M; Holz O; Vollmer E; Magnussen H; Jörres RA
Virchows Arch; 2007 Apr; 450(4):455-61. PubMed ID: 17377812
[TBL] [Abstract][Full Text] [Related]
15. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.
Gomes JA; Amankwah R; Powell-Richards A; Dua HS
Br J Ophthalmol; 2004 Jun; 88(6):821-5. PubMed ID: 15148219
[TBL] [Abstract][Full Text] [Related]
16. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
17. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
Dejmek A; Hjerpe A
Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
[TBL] [Abstract][Full Text] [Related]
18. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
Soini Y; Kinnula V; Kahlos K; Pääkkö P
J Clin Pathol; 2006 Mar; 59(3):250-4. PubMed ID: 16505274
[TBL] [Abstract][Full Text] [Related]
19. Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathy.
Sano N; Kitazawa K; Sugisaki T
Nephron; 2001 Dec; 89(4):416-21. PubMed ID: 11721159
[TBL] [Abstract][Full Text] [Related]
20. Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein.
Fries H; Elsässer HP; Mahlbacher V; Neumann K; Kern HF
Virchows Arch; 1994; 424(1):7-12. PubMed ID: 7526947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
